129269-48-3

Upstream product

• 81076-81-5 1,6-anhydro-3-O-benzyl-2,4-dideoxy-2-C-methyl-4-methylene-β-D-xylohexopyranose 
• 129269-47-2 (1R,3R,4R,5R)-3-Benzyloxy-2-hydroxymethyl-4-methyl-6,8-dioxa-bicyclo[3.2.1]octan-2-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 129269-47-2 (1R,2S,3R,4R,5R)-3-Benzyloxy-2-hydroxymethyl-4-methyl-6,8-dioxa-bicyclo[3.2.1]octan-2-ol 

Downstream Products

• 97321-52-3 C₁₅H₁₈O₄ 
• 97321-52-3 C₁₅H₁₈O₄ 
• 81099-75-4 1,6-anhydro-3-O-benzyl-2-desoxy-2,4-di-C-methyl-β-D-glucopyranose 

Relevant academic research and scientific papers

STEREO-CONTROLLED SYNTHESIS OF ERYTHRONOLIDES A AND B FROM 1,6-ANHYDRO-β-D-GLUCOPYRANOSE (LEVOGLUCOSAN). SKELETON ASSEMBLY IN (C9 - C13) + (C7 - C8) + (C1 - C6) SEQUENCE

Stereospecific syntheses of erythronolides A and B have been accomplished starting from 1,6-anhydro-β-D-glucopyranose (levoglucosan) in a uniform synthetic sequence.

SYNTHESIS OF MACROLIDE ANTIBIOTICS. 19. SYNTHESIS OF THE C7-C13 FRAGMENT OF ERYTHRONOLIDE A

A stereocontrolled synthesis was carried out for the C7-C13 fragment of erythronolide A in 33 steps with an overall yield of 13percent relative to starting levoglucosan.